The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
-
* Corresponding author: Michael A Becker mbecker@medicine.bsd.uchicago.edu
Arthritis Research & Therapy 2010, 12:R63 doi:10.1186/ar2978
See related editorial by Singh, http://arthritis-research.com/content/12/4/136
Accesses
- Last 30 days: 311 accesses
- Last 365 days: 3746 accesses
- All time: 9462 accesses
Cited by
BioMed Central: 3 citations
|
Robert L. Jackson, Barbara Hunt, Patricia A MacDonald BMC Geriatrics 2012, 12:11 (21 March 2012) |
|
African American patients with gout: efficacy and safety of febuxostat vs allopurinol Alvin F Wells, Patricia A MacDonald, Solomon Chefo, Robert L Jackson BMC Musculoskeletal Disorders 2012, 13:15 (9 February 2012) |
|
Advances in gout: some answers, more questions Jasvinder A Singh Arthritis Research & Therapy 2010, 12:136 (24 September 2010) |